Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
UBS generated almost as much profit before tax from its global banking and markets operations in the first quarter as it did across all of last year, it revealed on Tuesday. This was despite taking credit losses and marking down exposures. The bank benefitted from a good turnout in FX and rates and its heavy involvement in a shrunken M&A fee pool. -
The European Commission said on Tuesday that it would amend bank capital rules in the EU to free up more capacity for lending during the coronavirus pandemic. Its new measures include a proposal to reset the transitional period for IFRS 9, as well as several changes to leverage ratio requirements.
-
Norwegian video conferencing company Pexip has been hailed by equity capital markets bankers as an ideal IPO for the times amid a surge in remote working due to the Covid-19 global pandemic.
-
The possibility of oil prices returning to negative territory snapped back into focus on Monday, as the USO ETF, which holds a large proportion of West Texas Intermediate front month futures, decided to roll its positions this week.
-
More than £2.3bn ($2.86bn) of UK securitizations are coming up for call, as a majority of the year’s redemption schedule is packed into the current quarter. Investors expect banks to call as normal, but see non-bank deals as likely to miss their calls and extend.
-
Last week, IDB Invest raised $1bn with its largest deal ever, a $1bn two year fixed rate bond. Although the proceeds of the bond will not be segregated from its regular funding, the issuer is adding a “Covid-19 lens” to the framework used to assess its development effectiveness.
